This year, the Lupus Foundation of America is implementing numerous projects to achieve our goals to increase federal support for lupus research and services to benefit people with lupus, their families and caregivers. Find out more about two of our exciting endeavors in this letter from our CEO, Sandra C. Raymond.
On the outside, Josie Pearce seems like your average 17-year-old. You’d never know that just a few years ago Josie’s parents were taking her from doctor to doctor, trying to figure out why their once energetic daughter now spent days lying on the couch unable to move or attend the ballet classes she loved.
For people with chronic illnesses like lupus, affording monthly medications can be a struggle. Knowing your options can help when it comes to navigating the process of applying for funding assistance.
Ask The Experts: Sharon Mack, Health Educator for the Lupus Foundation of America, provides helpful tips and advice about caring for a loved one with lupus while caring for yourself.
When the Lupus Foundation of America became aware of a hydroxychloroquine (Plaquenil®) shortage, we set out to discover the root of problem. While we still have limited information, we want to alert our constituents to the facts of the situation.
With the steadily rising temperatures come the first Walk to End to Lupus Now™ events of 2015. Whether you’ve been involved for years or will be participating for the first time, these events are an incredible way to experience firsthand the power of the movement to end lupus.
At the 2014 American College of Rheumatology Annual Scientific Meeting, Dr. Sara K. Tedesch presented her study on the relationship between lupus activity prior to getting pregnant and during pregnancy. The Lupus Foundation of America conducted a Q&A with Dr. Tedeschi about her study.
Lupus-related kidney inflammation (lupus nephritis) is one of the most common and serious complications of lupus. However, a new study demonstrates that an understudied inflammation pathway in lupus may bring researchers closer to developing a novel blood-based test that could predict the progression of kidney failure.